Trial Profile
A Phase I Study of Lenalidomide Plus Chemotherapy With Mitoxantrone, Etoposide, and Cytarabine for the Reinduction of Patients With Acute Myelogenous Leukemia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Feb 2019
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Cytarabine; Etoposide; Mitoxantrone
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 08 Dec 2015 Status changed from recruiting to completed, according to results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology
- 17 Sep 2012 New trial record